Connect your AI

Evommune EVMN Asset Acquisition Consideration Transferred

Asset Acquisition Consideration Transferred at other companies

CareTrustCTRE

$211.93M+416%

Goosehead Insurance, Inc.GSHD

$115K—

Alliance Resource PartnersARLP

$1.72M+5,124%

DML

Dorchester MineralsDMLP

$0-100%

HRO

HarrowHROW

$4.09M—

InvenTrust PropertiesIVT

$122.98M—

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:AssetAcquisitionConsiderationTransferred.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's asset acquisition consideration transferred.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's asset acquisition consideration transferred?: Evommune (EVMN) reported asset acquisition consideration transferred of $450K in Q1 2026.